Ikarian Capital’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9M Buy
428,682
+50,000
+13% +$2.71M 3.56% 12
2025
Q4
$17.5M Buy
378,682
+67,000
+21% +$3M 2.26% 17
2025
Q3
$11.2M Buy
311,682
+6,682
+2% +$221K 2.27% 22
2025
Q2
$9.92M Buy
305,000
+105,000
+53% +$3.44M 3.28% 18
2025
Q1
$7.55M Buy
+200,000
New +$16M 2.46% 20
2023
Q4
Sell
-142,417
Closed -$7.26M 178
2023
Q3
$7.26M Buy
142,417
+2,417
+2% +$119K 2.7% 32
2023
Q2
$6.99M Sell
140,000
-85,000
-38% -$4.03M 2.47% 28
2023
Q1
$8.43M Sell
225,000
-25,000
-10% -$1.06M 3.5% 15
2022
Q4
$12M Buy
+250,000
New +$9.81M 4.97% 5
2022
Q3
Sell
-225,991
Closed -$4.92M 162
2022
Q2
$4.92M Sell
225,991
-90,000
-28% -$2.08M 2.04% 37
2022
Q1
$7.63M Buy
315,991
+20,880
+7% +$456K 2.32% 27
2021
Q4
$7.02M Hold
295,111
2.01% 26
2021
Q3
$7.49M Sell
295,111
-152,999
-34% -$3.71M 1.71% 49
2021
Q2
$10.1M Sell
448,110
-53,000
-11% -$1.09M 1.8% 34
2021
Q1
$9.9M Buy
501,110
+225,000
+81% +$5.66M 1.47% 70
2020
Q4
$7.34M Buy
276,110
+260,000
+1,614% +$9.67M 1.34% 72
2020
Q3
$796K Sell
16,110
-123,703
-88% -$4.93M 0.22% 132
2020
Q2
$4.42M Buy
+139,813
New +$4.5M 1.34% 72

Other funds holding PCVX